A Really Good Day(70)

Calderone, Julia. “The Rise of All-Purpose Antidepressants.” Scientific American, Nov. 1, 2014. At http://www.scientificamerican.com/?article/?the-rise-of-all-purpose-antidepressants/.

Carhart-Harris, R. L., M. Kaelen, M. Bolstridge, T. M. Williams, L. T. Williams, R. Underwood, A. Feilding, and D. J. Nutt. “The Paradoxical Psychological Effects of Lysergic Acid Diethylamide (LSD).” Psychological Medicine 46, no. 7 (2016): 1379–90. At doi: 10.1017/?S0033291715002901.

Carhart-Harris, Robin L., Mark Bolstridge, James Rucker, Camilla M. J. Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A. Rickard, Ben Forbes, Amanda Feilding, David Taylor, Steve Pilling, Valerie H. Curran, and David J. Nutt. “Psilocybin with Psychological Support for Treatment-resistant Depression: An Open-label Feasibility Study.” The Lancet 3, no. 7 (July 2016): 619–27. At http://www.thelancet.com/?journals/?lanpsy/?article/?PIIS2215-0366(16)30065-7/?abstract.

Compton, Wilson, and Nora Volkow. “Major Increases in Opioid Analgesic Abuse in the United States: Concerns and Strategies.” Drug and Alcohol Dependence 81 (May 2005): 103–7.

Dass, Ram. Be Here Now. New York: Crown Publishing, 1971.

Dodes, Lance M., and Zachary Dodes. The Sober Truth: Debunking the Bad Science Behind 12-Step Programs and the Rehab Industry. Boston: Beacon Press, 2014.

Dyck, Erika. Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore: Johns Hopkins University Press, 2008.

Fadiman, James, Ph.D. The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys. Rochester, Vt.: Park Street Press, 2011.

Fish, Jefferson M., ed. How to Legalize Drugs. North Bergen, N.J.: Book-mart Press, 1998.

Gayomali, Chris. “Forget Coffee, Silicon Valley’s New Productivity Hack Is ‘Microdoses’ of LSD.” Gentlemen’s Quarterly, Nov. 23, 2015. At http://www.gq.com/?story/?forget-coffee-silicon-valleys-new-productivity-hack-is-microdoses-of-lsd.

Glatter, Robert, M.D. “LSD Microdosing: The New Job Enhancer in Silicon Valley and Beyond?” Forbes, Nov. 27, 2015. At http://www.forbes.com/?sites/?robertglatter/?2015/?11/?27/?lsd-microdosing-the-new-job-enhancer-in-silicon-valley-and-beyond/?#3d455c9e114d.

Goldsmith, Neal M., Ph.D. Psychedelic Healing: The Promise of Entheogens for Psychotherapy and Spiritual Development. Rochester, Vt.: Healing Arts Press, 2011.

Gray, Mike. Drug Crazy: How We Got into This Mess and How We Can Get Out. New York: Random House, 1998.

Greenfield, Robert. Timothy Leary: A Biography. Orlando, Fla.: Harcourt, 2006.

Greenwald, Glenn. Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies. Washington, D.C.: Cato Institute, 2009.

Grob, Charles S., Alicia L. Danforth, Gurpreet S. Chopra, Marycie Hagerty, Charles R. McKay, Adam L. Halberstadt, and George R. Greer. “Pilot Study of Psilocybin Treatment for Anxiety in Patients with Advanced-Stage Cancer.” Archives of General Psychiatry 68, no. 1 (2011): 71–78. At doi: 10.1001/?archgenpsychiatry.2010.116.

Grof, Stanislav. Realms of the Human Unconscious: Observations from LSD Research. New York: Viking, 1975.

Gunten, Charles F. von. “The Pendulum Swings for Opioid Prescribing.” Journal of Palliative Medicine 19.4 (2016): 348.

Hagenbach, Leiter, and Lucius W?rthmüller. Mystic Chemist: The Life of Albert Hofmann and His Discovery of LSD. Trans. William Geuss and Linda Sperling. Santa Fe, N.M.: Synergetic Press, 2011.

Hart, Dr. Carl. High Price: A Neuroscientist’s Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society. New York: HarperCollins, 2013.

Hart, Carl L., Joanne Csete, and Don Habibi. “Methamphetamine: Fact vs. Fiction and Lessons from the Crack Hysteria.” Open Society Institute, Feb. 2014. At https://www.opensocietyfoundations.org/?publications/?methamphetamine-dangers-exaggerated.

Hart, Carl L., Caroline B. Marvin, Rae Silver, and Edward E. Smith. “Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical Review.” Neuropsychopharmacology 37, no. 3 (2011): 586–608. At http://www.ncbi.nlm.nih.gov/?pubmed/?22089317.

Hendricks, Peter S., Christopher B. Thorne, C. Brendan Clarke, David W. Coombs, and Matthew W. Johnson. “Classic Psychedelic Use Is Associated with Reduced Psychological Distress and Suicidality in the United States Adult Population.” Journal of Psychopharmacology 29, no. 3 (2015): 280–88. doi: 10.1177/?0269881114565653.

Henry, Brook L., Arpi Minassian, and William Perry. “Effect of Methamphetamine Dependence on Everyday Functional Ability.” Addictive Behaviors 35, no. 6 (2010): 593–98. At http://www.ncbi.nlm.nih.gov/?pubmed/?20167435.

Hintzen, Annelie, and Torsten Passie. The Pharmacology of LSD: A Critical Review. New York: Oxford University Press, 2010.

Hofmann, Albert, Ph.D. LSD, My Problem Child: Reflections on Sacred Drugs, Mysticism and Science. Trans. Jonathan Ott. Saline, Mich.: McNaughton & Gunn, 1983.

Holland, Julie, M.D. Moody Bitches. New York: Penguin, 2015.

Huxley, Aldous. The Doors of Perception and Heaven & Hell. New York: Thinking Ink, 2011.

Jamison, Kay Redfield. Touched with Fire. New York: Free Press Paperbacks, 1993.

———. An Unquiet Mind: A Memoir of Moods and Madness. New York: Random House, 1995.

Johnson, Matthew W., Albert Garcia-Romeu, Mary P. Cosimano, and Roland R. Griffiths. “Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction.” Journal of Psychopharmacology, Sept. 11, 2014. Last modified Oct. 16, 2014. At http://jop.sagepub.com/?content/?early/?2014/?09/?06/?0269881114548296.short.